BeOne Medicines Ltd.
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines UTB Additions — Prior Year Tax Positions by Year
UTB Additions — Prior Year Tax Positions ($M) ($M)
BeOne Medicines UTB Additions — Prior Year Tax Positions: $6M in FY2025. That is the highest of the 10 years on record here.
Latest, FY2025
6
Period ended Dec 31, 2025
Change on a year earlier
–
0 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Income Taxes Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | UTB Additions — Prior Year Tax Positions ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | – | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 0 | – | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 0 | – | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 0 | – | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 0 | – | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 0 | -100.0% | Form 10-K (filed 2023-02-27) ↗ |
| FY2019 | Dec 31, 2019 | 0.10 | – | Form 10-K (filed 2022-02-28) ↗ |
| FY2018 | Dec 31, 2018 | 0 | -100.0% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 0.20 | – | Form 10-K (filed 2020-03-02) ↗ |
| FY2016 | Dec 31, 2016 | 0 | – | Form 10-K (filed 2019-02-28) ↗ |
Cite this data
StockData. (2026). BeOne Medicines UTB Additions — Prior Year Tax Positions ($M), annual FY2016–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/utb-inc-prior
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.